Literature DB >> 15201789

Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: a comparative study.

Mustafa F Usta1, Trinity J Bivalacqua, Zafer Tokatli, Francesco Rivera, K Hakan Gulkesen, Suresh C Sikka, Wayne J G Hellstrom.   

Abstract

PURPOSE: Erectile dysfunction (ED) occurs in 20% to 54% of men with Peyronie's disease (PD). We investigated the role of vascular status in the pathophysiology of ED in patients with PD.
MATERIALS AND METHODS: A total of 509 consecutive men with PD (group 1--impotent 259, 1a, and potent 250, 1b, mean age +/- SD 54.6 +/- 4.4 years) and 507 consecutive men with ED only (group 2--mean age 49.4 +/- 12.4 years) underwent penile duplex ultrasonography (PDU). Detailed sexual and medical history, and focused physical examination were performed in all patients. Patients in the 2, groups were stratified according to age (18 to 80 years) and classified according to PDU results (normal vascular status, arterial insufficiency, veno-occlusive dysfunction [VOD] and mixed vascular pathology).
RESULTS: VOD was observed in 23.1% and 42.8% of patients in groups 1 and 2, respectively (p <0.05). Although VOD was significantly more common in group 2 (ED alone) than in group 1a (PD plus ED) in the third decade (p <0.05), overall PDU results showed no statistical difference for VOD between these 2 groups (p >0.05). Of note, mixed vascular pathologies were significantly higher in group 1a than in group 2 in the third through fifth decades (p <0.05), while arterial insufficiency was more common in the seventh decade (p <0.05).
CONCLUSIONS: While many groups have investigated the vascular causes of ED, the exact etiology of ED in men with PD remains controversial. A possible relationship between ED and VOD in patients with PD has been previously reported. The current PDU study demonstrates that for all ages except 30 to 39 years the prevalence of VOD in patients with PD plus ED is similar to that of patients with ED alone.

Entities:  

Mesh:

Year:  2004        PMID: 15201789     DOI: 10.1097/01.ju.0000132154.38285.c7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Current Status for Semirigid Penile Prosthetic Devices.

Authors:  Raul E Fernandez-Crespo; Kristina Buscaino; Justin Parker; Rafael Carrion
Journal:  Curr Urol Rep       Date:  2021-01-09       Impact factor: 3.092

2.  Corporoplasty with small soft axial prostheses (VIRILIS I®) and bovine pericardial graft (HYDRIX®) in Peyronie's disease.

Authors:  Alessandro Zucchi; Mauro Silvani; Stefano Pecoraro
Journal:  Asian J Androl       Date:  2013-01-28       Impact factor: 3.285

3.  The selective Rho-kinase inhibitor azaindole-1 has long-lasting erectile activity in the rat.

Authors:  George F Lasker; Edward A Pankey; Alexander V Allain; Subramanyam N Murthy; Johannes-Peter Stasch; Philip J Kadowitz
Journal:  Urology       Date:  2013-02       Impact factor: 2.649

4.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

5.  Intralesional collagenase Clostridium histolyticum for acute phase Peyronie's disease: a single-center, retrospective cohort study.

Authors:  Ming-Yeah Y Hu; John T Sigalos; Dyvon T Walker; Michelle K Li; Dar A Yoffe; Neilufar Modiri; Thomas W Gaither; Alvaro J Santamaria; Keith V Regets; Sriram V Eleswarapu; Jesse N Mills
Journal:  Transl Androl Urol       Date:  2022-08

6.  Peyronie's reconstruction for maximum length and girth gain: geometrical principles.

Authors:  Paulo H Egydio; Salvatore Sansalone
Journal:  Adv Urol       Date:  2008-12-03

Review 7.  Peyronie's disease: A contemporary review of non-surgical treatment.

Authors:  Laurence A Levine
Journal:  Arab J Urol       Date:  2013-05-28

Review 8.  Peyronie's disease: contemporary review of non-surgical treatment.

Authors:  Laurence A Levine
Journal:  Transl Androl Urol       Date:  2013-03

9.  Malleable Penile Implant Is an Effective Therapeutic Option in Men With Peyronie's Disease and Erectile Dysfunction.

Authors:  Mohamad Habous; Alaa Tealab; Mohammed Farag; Tarek Soliman; Ben Williamson; Saad Mahmoud; Amin Elserafy; Zenhom Mekawi; Abdallah Remeah; Mohammed Nassar; Osama Laban; Osama Abdelwahab; Saleh Binsaleh; Simone Giona; David Ralph; John Mulhall
Journal:  Sex Med       Date:  2018-01-11       Impact factor: 2.491

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.